Global Trust Asset Management LLC Has $3.38 Million Stock Position in McKesson Corporation $MCK

Global Trust Asset Management LLC lowered its position in McKesson Corporation (NYSE:MCK) by 13.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 4,120 shares of the company’s stock after selling 624 shares during the period. McKesson makes up 1.3% of Global Trust Asset Management LLC’s investment portfolio, making the stock its 20th largest holding. Global Trust Asset Management LLC’s holdings in McKesson were worth $3,379,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of MCK. GGM Financials LLC acquired a new position in shares of McKesson in the third quarter valued at $25,000. State of Wyoming bought a new position in McKesson in the second quarter worth $29,000. Hopwood Financial Services Inc. acquired a new stake in McKesson during the third quarter worth $31,000. Board of the Pension Protection Fund bought a new stake in McKesson in the 4th quarter valued at $33,000. Finally, Vermillion & White Wealth Management Group LLC bought a new stake in McKesson in the 3rd quarter valued at $33,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Activity at McKesson

In related news, EVP Leann B. Smith sold 190 shares of the stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the sale, the executive vice president directly owned 2,989 shares in the company, valued at $2,824,605. This represents a 5.98% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 3,868 shares of company stock valued at $3,743,820. Insiders own 0.08% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on MCK. Wall Street Zen raised shares of McKesson from a “hold” rating to a “buy” rating in a report on Sunday, March 22nd. Weiss Ratings cut shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, February 5th. Wells Fargo & Company increased their price target on shares of McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 5th. Raymond James Financial set a $970.00 price target on shares of McKesson in a research note on Thursday, March 5th. Finally, Barclays lifted their price objective on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a report on Wednesday, February 18th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $960.93.

McKesson Stock Performance

Shares of NYSE:MCK opened at $885.42 on Friday. The company’s fifty day moving average is $912.57 and its 200-day moving average is $844.55. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00. The company has a market capitalization of $108.45 billion, a PE ratio of 25.46, a P/E/G ratio of 1.26 and a beta of 0.42.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter last year, the company posted $8.03 EPS. The firm’s revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, analysts forecast that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd were issued a dividend of $0.82 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.